Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
about
Radiotherapy for advanced-stage aggressive non-Hodgkin lymphomaImage-guided radiation therapy in lymphoma managementChemotherapy only in early-stage Hodgkin lymphoma: more relapses but "same" (or possibly worse) survival--reconsidering the misguided trend to omit radiotherapyPediatric Exposures to Ionizing Radiation: Carcinogenic ConsiderationsInvolved-field radiotherapy for esophageal squamous cell carcinoma: theory and practiceRadiotherapy of follicular lymphoma: updated role and new rules.The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.Primary adrenal nodular lymphocyte-predominant Hodgkin lymphoma: A case report and review of the literaturePancreatic cancer risk after treatment of Hodgkin lymphomaUse of appropriate initial treatment among adolescents and young adults with cancer.The impact of protocol assignment for older adolescents with hodgkin lymphomaCardiovascular disease after cancer therapy.Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Risk of valvular heart disease after treatment for Hodgkin lymphomaPredictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphomaBeyond PET/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complications.Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphomaInvolved site radiation therapy for the treatment of early-stage Hodgkin lymphoma in adolescents and young adultsProton therapy in the management of non-Hodgkin lymphoma.Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases.Patterns of failure after involved field radiation therapy for pediatric and young adult Hodgkin lymphoma.The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma.Effect of Akimbo versus Raised Arm Positioning on Breast and Cardiopulmonary Dosimetry in Pediatric Hodgkin LymphomaVery low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literatureBalancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone.Chemotherapy alone or combined chemotherapy and involved field radiotherapy in favorable risk early-stage classical Hodgkin lymphoma-a 10 years experience.When should FDG-PET be used in the modern management of lymphoma?Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?Modern radiotherapeutic strategies in the management of lymphoma.Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment.The new therapeutical scenario of Hodgkin lymphoma.XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.The concept and evolution of involved site radiation therapy for lymphoma.ISRT: a new radiation therapy for malignant lymphomas: Introduction to the review article by Specht and Yahalom.Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.Radiation-related heart and vascular disease.PET-directed therapy in Hodgkin lymphoma: Ready for prime time?Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
P2860
Q24187708-7F498281-313E-4D2F-93B2-215A440F79AAQ26781339-27A08951-43A6-4092-A822-A32CC586D55AQ27015790-FBDEBF7A-98CE-431A-BEAB-7F6455FA877FQ28070290-2671C488-F7ED-4C6A-850A-19798ADCC120Q28073933-8578AA28-6A54-4167-A3D4-D8E8C1459AD4Q33713219-19BEC991-15AE-406D-8021-6AE9D0C8F29EQ33778385-EED6A490-C800-48A8-9B8F-BC7C61D71FA0Q33968094-5526992D-B257-4F37-9675-9D8E55CCFB58Q34250016-F33F338D-EA78-4EA7-A194-9219FDE22369Q34354175-A1A795F6-CEE7-4A13-9384-245CEC7088F1Q34582650-914A5B70-031E-4FAC-9016-7F3D65557335Q34604429-DAAB35E8-E25A-465B-B7D1-F1AA3C3CCF37Q34664223-82646219-85B3-47AA-AEA0-D9573E214E20Q35386920-EDAA0E4C-CCDA-4409-B264-93F72CFF20B1Q35564776-A01AD827-C380-4657-AF09-4BA891646BBEQ35650402-E8C4C28F-CCAB-433F-AF32-6AA011FDE313Q36092482-BA449D86-985B-4A41-86FA-04CCC71F509AQ36450854-DBFD0A5D-B4A1-4A46-A960-5C3F35734235Q36518955-775E2756-13FF-4CFF-AF5C-E8743AF89A8AQ36722784-B581C856-100F-40E3-B711-D14B90F85411Q36791057-497273CA-E02E-4652-9CC9-7F60BE2E8111Q37110145-C850F8AB-FFD8-4195-8D86-E34CCFD33A69Q37124918-45BC0C30-4D27-422A-9ECF-219CABBA2E10Q37149757-4CB419A0-390B-4F3E-9B74-0AAFF4D0860AQ37178817-8723F76A-78E6-498B-9054-40730AB434CBQ37383554-0C462118-A589-449B-8B3E-89592C3D0033Q37563122-C0178FB3-142B-42A9-8138-D583021D7389Q38153086-19BD8CF6-0014-410D-9C4B-ACDA577BA9BFQ38248237-F87E2BB9-CA0A-4C6A-BE13-293107E1B45CQ38373945-B1146491-EE0A-494A-88BE-3950ECE0B8C2Q38407140-0FB40562-6157-48DD-8823-E9AD1B951105Q38513816-45642ACA-DBA2-4E1A-95C7-B967B9AAB901Q38524029-35A6C130-EB46-4E31-A556-8DAA322F4278Q38543470-2171B056-8A98-494E-BCD1-EC8B32847DCBQ38545142-293E5AA4-F679-4AC4-B696-7B786A00DC10Q38549745-CF9BD228-30BB-4A51-B10D-19F333AB6184Q38551769-A921FCDE-3F09-4AC3-A19A-881F5752A3C3Q38608555-435B43BB-E5CE-4B27-87D9-5644370B4E46Q38654138-497E3724-C30D-4AED-B7B4-69F000978F9FQ38688797-99EE8B56-795A-4E24-9D56-E4A4CED724DD
P2860
Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Modern radiation therapy for H ...... iation oncology group (ILROG).
@en
type
label
Modern radiation therapy for H ...... iation oncology group (ILROG).
@en
prefLabel
Modern radiation therapy for H ...... iation oncology group (ILROG).
@en
P2093
P1476
Modern radiation therapy for H ...... iation oncology group (ILROG).
@en
P2093
Anne Kiil Berthelsen
Hans Theodor Eich
Joachim Yahalom
Louis S Constine
N George Mikhaeel
Peter Mauch
Richard T Hoppe
Theodore Girinsky
P304
P356
10.1016/J.IJROBP.2013.05.005
P407
P577
2013-06-18T00:00:00Z